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Abstract
Background—Cholecystectomy has been identified as a risk factor for colorectal cancer, yet little
attention has been given to the association between cholecystectomy and colorectal adenomas.
Methods—We utilized data collected in two large cross-sectional studies of colorectal adenoma
risk factors to examine the association between cholecystectomy and colorectal adenomas.
Consecutive patients undergoing colonoscopies at the University of North Carolina Hospitals were
recruited into the studies. Diet and lifestyle questionnaires were given to participants within twelve
weeks of their colonoscopy. Logistic regression was used to estimate the prevalence odds ratios
overall, by site of adenoma, and by time since cholecystectomy.
Results—In the adjusted logistic regression model, both men and women showed no effect of
cholecystectomy on risk of colorectal adenomas. The point estimates for men and women were in
opposite directions (men: odds ratio (OR) 0.67; 95% confidence interval (CI) 0.30, 1.47; women:
OR 1.46; 95% CI 0.92, 2.29). No effect was seen when examining the time since cholecystectomy
for men (cholecystectomy at least ten years prior to entering the study: OR 0.94; 95% CI 0.28, 3.22;
cholecystectomy less than ten years prior: OR 0.53; 95% CI 0.19, 1.50) or women (cholecystectomy
at least ten years prior 1.14 [95% CI 0.62, 2.09], cholecystectomy less than ten years prior 2.02 [95%
CI 1.06, 3.87]).
Conclusion—We conclude that there is no simple relationship between factors that result from
cholecystectomy, such as exposure of the colon to bile salts, and colorectal adenoma risk.
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INTRODUCTION
Cholecystectomy remains one of the most commonly performed operations in the United
States. The rates of cholecystectomy have fluctuated in the United States but have remained
consistently above 150 per 100,000 people per year since the 1990s (1). With this number of
cholecystectomies being performed, it is important to understand the potential health risks
associated with this procedure. One outcome that has not been thoroughly addressed is the
possibility of an association between cholecystectomy and colorectal adenomas.
Correspondence to: Lisa C. Vinikoor.
Requests for reprints: Lisa C. Vinikoor, Department of Epidemiology/CGIBD, CB#7555, University of North Carolina, Chapel Hill,
NC 27599-7555. Phone: 919-966-0090; Fax: 919-966-2478; E-mail: vinikoor@email.unc.edu..
NIH Public Access
Author Manuscript
Dig Dis Sci. Author manuscript; available in PMC 2009 March 1.
Published in final edited form as:













Many studies have examined the association between cholecystectomy and colorectal cancer.
Two meta-analyses have reported an increased risk of colorectal cancer in those who have
undergone a cholecystectomy (2,3). Some, but not all, of the studies used in the two meta-
analyses overlapped. Both meta-analyses found that the risk of colorectal cancer was higher
in the right side of the colon. They also demonstrated a higher risk in women. Since the
publication of the meta-analyses, more studies have been published looking at this association.
Some found an increase in the risk of proximal colon tumors (3,4). One study reported an
increase in sigmoid tumors for women that had undergone a cholecystectomy (6). A study
performed only in women found that there was an increase in cancer associated with
cholecystectomy, and more specifically, an increase in the risk of proximal colon and rectal
cancer (7). Other studies showed an increased risk of colon cancer after cholecystectomy but
no increase for rectal cancer (8) or no association at all between cholecystectomy and advanced
colonic neoplasia (9).
While there have been a number of studies evaluating the association between cholecystectomy
and cancer, few have studied the association between cholecystectomy and colorectal
adenomas. The meta-analyses performed by Giovannucci et al. analyzed a subset of papers
reporting on colorectal adenoma risk as well colorectal cancer risk (3). Many of the studies
lacked an adequate sample size to investigate the association between cholecystectomy and
increased risk of colorectal adenomas, and few studies controlled for potential confounders,
particularly potentially important confounders such as diet (2,3). Failure to account for an
induction period may also have affected the findings (3).
Two possible mechanisms have been suggested for the relationship between cholecystectomy
and colorectal neoplasia. First, cholecystectomy might operate to speed the transition of
adenomas to cancer. Alternatively, cholecystectomy might increase the risk for adenomas,
thereby creating more opportunities for the development of colorectal cancer. Determining
which of the above two possible mechanisms is correct will not only provide etiologic
information for understanding of the development of colorectal cancer but could potentially
have policy and procedural implications. For example, if the increased risk is related to the
progression of adenomas into cancer, patients (and their doctors) might take more aggressive
measures in terms of screening. In addition, those at higher risk might elect to further modify
their lifestyle to lower their risk. In order to further clarify the association between
cholecystectomy and colorectal adenomas, we conducted a hospital-based cross-sectional
study of cholecystectomy and adenomas that collected information on possible confounders,
effect measure modifiers, location of the adenomas in the colon, and time interval between
cholecystectomy and adenoma development.
METHODS
Study Population
The Diet and Health Study III (DHS III) and the Diet and Health Study IV (DHS IV) recruited
consecutive patients undergoing an outpatient colonoscopy at the University of North Carolina
Hospitals in Chapel Hill, North Carolina from August 1998 to March 2000 (DHS III) and from
November 2001 to December 2002 (DHS IV). Eligible patients were between the ages of 30
and 80. Patients were excluded if they did not speak English, or had familial polyposis, colitis,
previous colonic resection, or previous colon cancer or adenoma. Eligible patients were asked
to consent to a telephone-administered interview and to a rectal biopsy of normal mucosa
collected during the colonoscopy.
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There were 5621 colonoscopies performed at the University of North Carolina Hospitals during
the study period. Of these, 1677 (30%) were eligible to participate in the study. Exclusions
were due to: age (n=464), familial polyposis (n=10), colitis (n=710), previous colonic resection
(n=518), previous colon cancer or adenoma (n=1224), unsatisfactory prep (n=250), and
incomplete exam (n=239). These reasons are not mutually exclusive. Of the 1677 eligible
patients (926 from DHS III and 751 from DHS IV), 1437 (86%) consented to be a part of the
study and completed the telephone interview. The primary indication for colonoscopy was
screening for the vast majority of participants.
A telephone interview was conducted within twelve weeks of the colonoscopy. Patients were
asked questions about their lifestyle, including physical activity (asking both amount of time
spent doing activities and how strenuous these activities were, which were later converted to
metabolic equivalents per day), use of non-steroidal anti-inflammatory drugs (NSAIDs)
(asking how many times per day or week a person used NSAIDs), and medical conditions/
operations. They were also given a detailed dietary questionnaire. The participants of DHS III
were given a modified version of the Block Food Frequency Questionnaire (10,11).
Modification to the questionnaire was made in order to include foods more common in North
Carolina, such as hush puppies and black-eyed peas. Subjects in DHS IV were given the NCI
Diet History Questionnaire (12). All subjects were asked to report their diet over the past year
(allowing for seasonal fluctuations in patterns of consumption). Participants were questioned
about dietary supplements as well.
Since two different dietary questionnaires were used, the values for dietary variables between
DHS III and DHS IV could not be directly combined. Instead, the variables were divided into
quartiles based on the controls for each study and then combined using their assigned quartile
resulting in categorical dietary variables for each participant.
Data Analysis
Cases were defined as participants who had a colorectal adenoma detected. Location and size
of the adenoma were also noted. Participants with no adenomas detected were defined as
controls. If a person received a diagnosis of colorectal cancer, they were excluded from the
analysis.
Information on cholecystectomy was collected during the telephone interview. Participants
were asked if they ever had a cholecystectomy, and, if so, how long ago they underwent this
procedure.
Missing exposure data was assessed in order to determine if information was missing
differentially by outcome. Information about past cholecystectomies was missing for 7.29%
of the cases and 7.11% of the controls. While it does not appear that missing exposure data
was affected by outcome, those missing this information were excluded from the analysis.
Logistic regression was used to model the data. Prevalence odds ratios and 95% confidence
intervals were calculated using STATA/SE (STATA Corp. 2005. Statistical Software: version
8.2. College Station, TX). In the main analysis, case-control status was used as the outcome
variable and prior cholecystectomy was the exposure variable. The following variables were
assessed for effect measure modification and for confounding: age (coded as a continuous
variable), race (coded as white and non-white), sex (coded as a binary variable), smoking
(coded as an indicator variable with three categories: never, former, and current smoker), body
mass index (BMI) (coded as a continuous variable), physical activity (coded continuously using
current met-minutes per day), NSAID use (coded continuously as number of pills per month),
and dietary variables measuring calories, fat, carbohydrates, and fiber consumed (each of these
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was coded categorically in quartiles using the afore mentioned methods). Examination for
effect measure modification was performed using the Breslow-Day Test of Homogeneity. A
p-value of 0.15 was used as the cut-off value for classifying a variable as an effect measure
modifier. If a variable was determined to be an effect measure modifier, it was entered into the
final model along with an interaction term. Prevalence odds ratios and 95% confidence intervals
were calculated within each stratum of this variable. Linearity of the logit was also assessed
in order to verify the linearity assumption of logistic modeling. All of the variables satisfied
this assumption and thus no additional indicator variables were used. Confounding by the
variables of interest was assessed using the change-inestimate approach through backward
elimination. The change-in-estimate between the “full” model and the model without the
variable of interest was calculated. If the change was greater than 10% then the variable was
considered to be a confounder. In order to avoid deleting observations with missing information
on certain covariates, multiple imputation was performed. A regression was run using the
missing variable as the dependent variable. The independent variables were those that might
allow us to discern the value of this missing variable. The regression was run multiple times
and the results were combined to form a single estimate.
A secondary analysis was undertaken to examine if the risk of colorectal adenomas was greater
on a specific side of the colon. Prevalence odds ratios and 95% confidence intervals within the
strata of any previously determined effect measure modifier were calculated for the left and
right sides of the colon using the controls as the common referent. Adjustments were made for
any variables already determined to be confounders. The right side of the colon was defined
as the cecum, ascending colon, hepatic flexure, and transverse colon. The left side of the colon
was considered the splenic flexure, descending colon, sigmoid colon, and rectum. If a person
had an adenoma detected on both the left and right sides of their colon they were excluded
from this analysis.
Another analysis was performed to examine the possible change in risk with time since
undergoing a cholecystectomy. This was done by categorizing participants based on the amount
of time that had passed since their cholecystectomy. Prior studies have used a cut-point of ten
years (13,14). Therefore, we categorized people as never having a cholecystectomy, having
had a cholecystectomy performed less than 10 years before their enrollment in the study, and
having undergone a cholecystectomy ten years or more before becoming part of the study.
Then, the prevalence odds ratios and 95% confidence intervals were calculated with adjustment
for any previously determined confounders and within the stratum of any effect measure
modifiers using the group that never had a cholecystectomy as the referent population.
RESULTS
A total of 1,437 patients were included in the final study population. Of these, 425 were cases
(29.58%) and 1,012 were controls (70.42%). One hundred fifty-one participants had undergone
a cholecystectomy (11.32%). There were more women than men, with women comprising
approximately 57% of the study population. The mean age was 56 years. Table 1 gives the
characteristics of the study population by case and control status. Cases were older than controls
and had slightly higher BMIs. Cases also included more men than women, whereas controls
had a higher proportion of women than men. Women in the study population were slightly
older than the men, and a higher percentage of women than men had undergone a
cholecystectomy.
The only effect measure modifier among the variables of interest was sex. The change-in-
estimate approach yielded six confounders. All variables found to be confounders using the
change-in-estimate approach were adjusted for in the analyses. The confounders of the
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prevalence odds ratio were calories (categorical), age (continuous), race (categorical), BMI
(continuous), NSAID use (continuous), and daily physical activity (continuous).
When controlling for these confounders the prevalence odds ratios (POR) and their respective
95% confidence intervals were 0.67 (95% CI: 0.30, 1.47) for men and 1.46 (95% CI: 0.92,
2.29) for women (Table 2). While the 95% confidence intervals for men and women included
the null values, the prevalence odds ratios were in different directions. The adjusted estimates
suggest that the risk of colorectal adenomas is decreased for men who underwent
cholecystectomy. The risk of colorectal adenomas was increased in women. When considering
not only the point estimates but the 95% confidence intervals as well, our study shows no effect
of cholecystectomy on the risk of colorectal adenomas.
We attempted to determine whether risk increased for adenomas of the left or right side of the
colon. Of the 425 cases in the study, 1 was missing information on location, 148 had adenomas
of the left colon, 225 had adenomas of the right colon, and 51 had adenomas on both the left
and right colon. There were not enough men to support analysis. Only 2 men in the study
population who had undergone a cholecystectomy had an adenoma detected only on the left
side of their colon and only to 6 men had solely right-sided adenomas. Women, on the other
hand, had adequate numbers to conduct the analysis but no increase in risk for either side was
seen. When compared to controls, the prevalence odds ratio (and 95% confidence interval) for
women having an adenoma detected on the left side of the colon was 1.37 (95% CI: 0.70, 2.67).
The prevalence odds ratio (and 95% confidence interval) for right-sided adenomas was 1.44
(95% CI: 0.78, 2.66).
In the ten years prior to entering the study, 70 people had cholecystectomies whereas 76 people
had undergone a cholecystectomy at least ten years before their enrollment in the study. Men
showed a decrease in the protective effect of cholecystectomy with increased time since
cholecystectomy; however both odds ratios include the null and potentially show no effect of
cholecystectomy on the risk of colorectal adenomas (Table 3). For women, there appears to be
a slight increase in risk with cholecystectomy less than ten years prior (Table 3). This risk
decreases towards the null when examining women who had a cholecystectomy at least ten
years before entering the study. Of importance, however, is the mean time since
cholecystectomy of study participants (Table 4). For women the median number of years since
cholecystectomy was 11.0 years, with a mean of 13.9 years (SE 11.6 years). The median and
mean number of years since their cholecystectomy for men was 5.5 years and 8.8 years (SE
9.5), respectively. The differences between the mean times since cholecystectomy were not
statistically significant when comparing cases and controls for men (p=0.29) or women
(p=0.39). The difference in the mean time since cholecystectomy for women and men was 5.1
years (p-value of 0.0130), showing that the men in our study had a much shorter period of time
between cholecystectomy and colonoscopy when compared with the women in our study.
DISCUSSION
When controlling for confounders, this study found that cholecystectomy reduced the risk of
developing colorectal adenomas for men. The risk was reduced more than 30% in men who
underwent a cholecystectomy compared with men who did not. The 95% confidence interval
for this odds ratio, as well as the confidence intervals for the time since cholecystectomy
analysis are wide and include the null. A protective effect has not been demonstrated in past
studies, but very few studies have had adequate samples of men. Prior studies with sizeable
numbers of men have shown no effect of cholecystectomy in men (13,15-18). While our study
showed a protective affect when examining the point estimate, the confidence intervals show
no effect of cholecystectomy.
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In contrast, we found an increased risk of colorectal adenomas for women but this also was
not statistically significant. The same was found in sub-analysis of both the side of the colon
and the time since cholecystectomy. The effect seen in women is similar to other studies that
found null values after adjusting for confounders (16,17). Other studies that have found an
increased risk in women had either small sample size or found an increase only in the rectum
(7,13,15,18)
When looking at both sexes, the time since cholecystectomy affects the magnitude of the risk.
For men, cholecystectomy becomes less protective when men have had a cholecystectomy ten
or more years prior. For women, the elevated risk decreases. Though the point estimate of the
odds ratio for both men and women moves closer to the null, the confidence intervals are too
wide to estimate a change of risk with time. Two prior studies found an increased risk colorectal
adenomas with time since cholecystectomy, however these were performed in people 60 years
of age and older who had a cholecystectomy performed at least ten years prior (13,14). The
study population used in our analysis was not large enough to assess that age group alone. We
did however control for age in our analysis.
It has been proposed that removing the gallbladder exposes the intestines to a constant low-
level flow of bile, which may modify the environment of the colon (3,4). If bile salts were the
sole mechanism one would expect to observe similar effects in men and women, which is not
the case. Also, increasing time does not have an effect on risk. Thus, longer exposure to bile
is not increasing the risk of colorectal adenomas. Because there appears to be an increased risk
of colorectal cancer following cholecystectomy (2,3), and because our study has shown that
there is no increase in risk for colorectal adenomas, the effects of cholecystectomy on risk of
colorectal cancer must occur later in the neoplastic process, after the development of the
adenoma. The observed difference in risk when adenomas are the outcome measure, as opposed
to cancer as the outcome illustrates that different risk factors may occur at different points in
the adenoma-carcinoma sequence. Furthermore, the observation illustrates the hazards of using
intermediate markers, such as adenomas, as endpoints, as they might falsely reject a risk for
cancer. However, caution must be taken not to remove people with adenomas from the control
group in case-control studies of cholecystectomy and colorectal cancer. Doing this not only
has the potential to bias the results but the trohoc fallacy is also committed (19).
While this study contributes to the knowledge of cholecystectomy and risk of colorectal
adenomas, it has limitations. First, the sample size is small, limiting further analysis and
decreasing precision. Also, the information on cholecystectomy was missing for approximately
7% of the study participants. Finally, dietary practices are assumed to be relatively constant
throughout life. If, however, this is not the case, then information on diet ten or so years prior
may have been more informative than the diet recorded and studied in DHS III and DHS IV.
In sum, the present study suggests that cholecystectomy affects the risk of colorectal adenomas
differently for men and women. There is no difference seen for the length of time after a
cholecystectomy. Future studies of cholecystectomy and adenoma risk should examine men
and women separately. Work should be done to look at biologic factors besides bile salts that
may create an increased risk in adenoma becoming cancerous.
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Table 1
Characteristics of cases and controls, Diet and Health Studies III and IV*
Colorectal Adenoma (cases) N=425 No Colorectal Adenoma (controls)N=1,012
Cholecystectomy (%) 45 (11.42) 106 (11.28)
Male Sex (%) 240 (56.47) 373 (36.86)
White Race (%) 325 (79.46) 774 (79.06)
Smoking Status (%)
Never 180 (46.04) 476 (50.64)
Former 148 (37.85) 320 (34.04)
Current smoker 63 (16.11) 144 (15.32)
Age (%)
< 40 years 11 (2.70) 68 (7.03)
40-49 years 59 (14.46) 218 (22.54)
50-59 years 163 (39.95) 369 (38.16)
60-69 years 98 (24.02) 217 (22.44)
≥ 70 years 77 (18.87) 95 (9.82)
Mean Age (SD) 58.62 (10.24) 54.90 (10.69)
Body Mass Index (BMI) (%)
< 25.0 138 (33.33) 398 (40.57)
25.0-29.9 137 (33.09) 324 (33.03)
≥ 30 139 (33.57) 259 (26.40)
Mean BMI (SD) 28.27 (6.05) 27.38 (6.13)
*
Calculated by using values prior to imputation
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Table 2
Association between colorectal adenomas and cholecystectomy by sex
N Cases N Controls Prevalence Odds Ratio* 95% Confidence Interval*
Men
Cholecystectomy 10 22 0.67 0.30, 1.47
No cholecystectomy 206 323 1.00
Women
Cholecystectomy 35 84 1.46 0.92, 2.29
No cholecystectomy 143 511 1.00
*
Adjusted for age, BMI, NSAID use, calorie consumption, physical activity, and race
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Table 3
Association of colorectal adenomas and cholecystectomy by time since cholecystectomy and sex
N Cases N Controls Prevalence Odds Ratio* 95% Confidence Interval*
Men
< 10 years 5 16 0.53 0.19, 1.50
≥ 10 Years 5 6 0.94 0.28, 3.22
No cholecystectomy 206 323 1.00
Women
< 10 Years 16 33 2.02 1.06, 3.87
≥ 10 Years 17 48 1.14 0.62, 2.09
No cholecystectomy 143 511 1.00
*
Adjusted for age, BMI, NSAID use, calorie consumption, physical activity, and race
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